GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, will present additional data from both the NHS-Galleri trial and the PATHFINDER 2 study further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results